Numerous studies have revealed that TP53, CDKN2A, and KRAS mutations promoted invasion, metastasis, and immune escape in PACA patients, resulting in worse prognosis (Hu et al., 2018; Hashimoto et al., 2019). This evidence concerns the gene TP53 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.